Posted on 4/7/20
Akebia Therapeutics Appoints Myles Wolf to Board
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease
Posted on 4/7/20
Bruce Lisman to Join CIRCOR Board
BURLINGTON, Mass.--(BUSINESS WIRE)--CIRCOR International, Inc. (NYSE:CIR), a leading provider of severe service flow control solutions and other highly engineered products for the Industrial and Aerospace & . . .
Posted on 4/7/20
Exicure Appoints Timothy P. Walbert as Chairman of the Board
Exicure, Inc. (NASDAQ:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid technology, today reported Timothy P. Walbert, Chairman
Posted on 4/6/20
Jörgen Remmelg Named CEO of XMReality
XMReality, Inc. today announced that Jörgen Remmelg, former senior vice president at international high-tech company
Posted on 4/6/20
Brooks Automation Names Erica McLaughlin to Its Board
Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Erica McLaughlin has been elected to its Board of Directors.
Posted on 4/6/20
Constellation Pharmaceuticals Appoints Dr. Richard Levy to Board of Directors
CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop . . .
Posted on 4/3/20
Kaleido Biosciences Appoints Anne Prener to Board
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health
Posted on 4/2/20
Replimune Appoints Dieter Weinand as Chairman
Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced the appointment of Dieter Weinand
Posted on 3/31/20
Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals,
BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company commercializing a proprietary biomedical signal processing platform
Posted on 3/31/20
Rhythm Pharmaceuticals Appoints Hunter Smith as Interim CEO
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies
Posted on 3/30/20
Aware Appoints Peter Faubert to Board
Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, announced that the Aware Board of Directors has appointed Peter R. Faubert
Posted on 3/30/20
GTY Technology Appoints TJ Parass as CEO
GTY Technology Holdings Inc. (Nasdaq: GTYH), a leading vertical SaaS/Cloud solution for the public sector, announced today the appointment of TJ Parass as Chief Executive Officer
Posted on 3/29/20
Immuneering Expands Oncology Scientific Advisory Board
Immuneering Corporation today announced the addition of three leading oncology experts to the company’s Scientific Advisory Board (SAB).
Posted on 3/25/20
Affirmed Networks Names Anand Krishnamurthy as CEO
Affirmed Networks, the leader in virtualized, cloud-native 5G networks, today announced that its board of directors
Posted on 3/25/20
Ohana Biosciences Appoints David Sable, M.D., To Board
Ohana Biosciences, a clinical-stage biotechnology company pioneering reproductive health through the industry’s first sperm biology platform
Posted on 3/25/20
Q&A with Josef B. Volman, Co-Chair of the Business Law Group at Burns & Levinson
In this series, Burns & Levinson attorneys will help businesses and individuals navigate the many challenges that COVID-19 presents. In this installment, Joe Volman looks at . . .
Posted on 3/26/20
Q&A with Paul Mastrocola, Co-Chair of the Business Litigation & Dispute Resolution Group at Burns & Levinson
In this series, Burns & Levinson attorneys will help businesses and individuals navigate the many challenges that COVID-19 presents. In this installment, Paul Mastrocola discusses employment . . .
Posted on 3/24/20
Diamond S Shipping Announces Changes to Its Board of Directors
GREENWICH, Conn.--(BUSINESS WIRE)--Diamond S Shipping Inc. (NYSE: DSSI) announced today that Mr. Gerasimos Ventouris has resigned from the Company’s Board of Directors, effective March 23, 2020. . . .
Posted on 3/24/20
Freight Farms Appoints Rick Vanzura CEO
Freight Farms, the global innovation leader of containerized vertical farming with the world's largest network of IoT-connected farms
Posted on 3/24/20
Akcea Therapeutics Appoints Dr. Damien McDevitt as CEO
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., announced today that its board of directors has appointed Damien McDevitt, Ph.D. as Chief . . .
Posted on 3/23/20
Seres Therapeutics Appoints Paul Biondi To Board
Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Paul Biondi, Executive Partner at Flagship Pioneering, to its Board of Directors
Posted on 3/22/20
The Morganti Group Names Thamer Rushaidat CEO
The Morganti Group Inc., a 104-year-old construction company, has named Thamer Rushaidat as its new President
Posted on 3/20/20
Gundalow Company Elects John Lamson as Chairman of the Board
The Gundalow Company, a nonprofit organization whose mission is to protect the Piscataqua Region’s maritime heritage and environment through education and action,
Posted on 3/20/20
Mark Osborne to Join ePropelled's Commercial Advisory Board
ePropelled, a leader in magnetic engineering technology for electro-magnetic motors, today announced the appointment of Mark Osborne to the company's Commercial Advisory Board. "We are lucky . . .
Posted on 3/19/20
Emulate Appoints Jim Corbett as Chief Executive Officer
Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s . . .
Boston
